Accumulation of calbindin in cortical pyramidal cells with ageing; a putative protective mechanism which fails in Alzheimer's disease.

Accumulation of calbindin in cortical pyramidal cells with ageing; a putative protective mechanism which fails in Alzheimer's disease.

There is considerable interest in the status of calbindin immunoreactive neurones in Alzheimer's disease (AD) but previous studies have produced widely differing results. Here we describe calbindin neurones in temporal neocortex from 18 severely demented patients with neuropathologically confir...

Bibliografske podrobnosti
Main Authors:	Greene, JR, Radenahmad, N, Wilcock, G, Neal, J, Pearson, R
Format:	Journal article
Jezik:	English
Izdano:	2001

Podobne knjige/članki

A neurofilament antibody recognizes a subset of pyramidal cells in the human neocortex that are preserved in Alzheimer's disease.
od: Radenahmad, N, et al.
Izdano: (2003)

SOME OBSERVATIONS ON THE DISTRIBUTION OF CORTICAL TANGLES IN ALZHEIMERS-DISEASE
od: Esiri, M, et al.
Izdano: (1985)

Age and Alzheimer's disease.
od: Wilcock, G, et al.
Izdano: (1983)

Reduced density of calbindin-immunoreactive interneurons in the planum temporale in schizophrenia.
od: Chance, SA, et al.
Izdano: (2005)

Reduced density of calbindin immunoreactive interneurons in the planum temporale in schizophrenia
od: Chance, SA, et al.
Izdano: (2004)

The nucleus basalis in Alzheimer's disease: cell counts and cortical biochemistry.
od: Wilcock, G, et al.
Izdano: (1983)

Examining the influence of pyramidal neuron progenitor type on cortical subnetworks
od: Gothard, G
Izdano: (2023)

Why are drug trials in Alzheimer's disease failing?
od: Smith, A
Izdano: (2010)

Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia.
od: Hansen, L, et al.
Izdano: (1998)

The density of zeros of forms for which weak approximation fails
od: Heath-Brown, D
Izdano: (1992)

Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.
od: Wilcock, G, et al.
Izdano: (1982)

Cortical diffusivity investigation in posterior cortical atrophy and typical Alzheimer's disease
od: Torso, M, et al.
Izdano: (2020)

A credit accumulation system : an alternative to GPA and pass-fail /
od: 442421 Sheleff, Leon (Shaskolsky)

The pupillary light reflex in aging and Alzheimer's disease.
od: Tales, A, et al.
Izdano: (2001)

Pyramids
od: Bertrand, Marianne, et al.
Izdano: (2011)

Pyramid /
od: 367573 Macaulay, David
Izdano: (1975)

Visual attention in ageing, mild cognitive impairment and Alzheimer's disease
od: Tales, A, et al.
Izdano: (2002)

CHAMBER: Calcium-binding proteins (calretinin, calbindin, and parvalbumin) with Nissl staining on parasagittal sections of mouse brain
od: Nakamura, K, et al.
Izdano: (2019)

The expression of calbindin 1 and 2 proteins in human tissues and common tumours outside the central nervous system
od: Cross, S, et al.
Izdano: (2004)

THE RELATIONSHIP OF ARGYROPHILIC PLAQUES AND NEUROFIBRILLARY TANGLES TO THE SEVERITY OF DEMENTIA AND CORTICAL CHOLINE ACETYL TRANSFERASE LEVELS IN ALZHEIMERS-DISEASE
od: Wilcock, G, et al.
Izdano: (1983)

APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
od: Chalmers, K, et al.
Izdano: (2003)

Cognitive reserve, cortical plasticity and resistance to Alzheimer's disease.
od: Esiri, M, et al.
Izdano: (2012)

C1q, a small molecule with high impact on brain development: putative role for aging processes and the occurrence of Alzheimer’s disease
od: Rupprecht, C, et al.
Izdano: (2021)

GABAergic and pyramidal neurons of deep cortical layers directly receive and differently integrate callosal input.
od: Karayannis, T, et al.
Izdano: (2007)

Cholinesterase inhibitor treatment increases phosphotau accumulation in Alzheimer's disease but reduces A beta in dementia with Lewy bodies
od: Chalmers, K, et al.
Izdano: (2008)

Quaternionic Representation of the Riesz Pyramid for Video Magnification
od: Wadhwa, Neal, et al.
Izdano: (2014)

The complete pyramids /
od: 432528 Lehner, Mark
Izdano: (1997)

Neurotrophins in Alzheimer's disease
od: Wilcock, G
Izdano: (2002)

Treatment for Alzheimer's disease.
od: Wilcock, G
Izdano: (2000)

Riesz pyramids for fast phase-based video magnification
od: Wadhwa, Neal, et al.
Izdano: (2015)

TACRINE AND LECITHIN IN ALZHEIMERS-DISEASE
od: Wilcock, G
Izdano: (1990)

Alzheimer's disease--current issues.
od: Wilcock, G
Izdano: (1988)

Treating Alzheimer's disease.
od: Wilcock, G, et al.
Izdano: (1995)

Galantamine in Alzheimer's disease.
od: Razay, G, et al.
Izdano: (2008)

Velnacrine for Alzheimer's disease.
od: Birks, J, et al.
Izdano: (2004)

Hyperinsulinaemia and Alzheimer's disease.
od: Razay, G, et al.
Izdano: (1994)

Age and disability accumulation in multiple sclerosis.
od: Scalfari, A, et al.
Izdano: (2011)

Effects of selective silencing of layer 5 pyramidal neurons on sleep-wake distribution and local cortical EEG activity
od: Krone, L, et al.
Izdano: (2018)

Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease.
od: Pearson, R, et al.
Izdano: (1985)

Bumpy pyramid folding
od: Abel, Zachary Ryan, et al.
Izdano: (2015)